Andrew Hykes, Chief Operating Officer at Inari Medical, Inc. (NARI), sold 17,600 shares at $73.14 ($1.3M) on 2022-10-20, disclosed to the SEC on 2022-10-24.
Open-market sale of $1.3M NARI by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.45 | 1,544 | $110K | 8.7% |
| 2 | $71.45 | 1,544 | $110K | 8.7% |
| 3 | $72.04 | 4,491 | $324K | 25.4% |
| 4 | $72.04 | 4,491 | $324K | 25.4% |
| 5 | $73.14 | 2,565 | $188K | 14.7% |
| 6 | $73.14 | 2,565 |
| $188K |
| 14.7% |
| 7 | $73.88 | 400 | $30K | 2.3% |
| Total | $72.30 avg | 17,600 | $1.3M | 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $150K | — | Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-24 | $166K | — | Filing → |